[1]
Ratu Hazlisa, D. et al. 2026. Cost-Effectiveness Analysis of Simvastatin and Atorvastatin in Hypertensive patients with type 2 Diabetes Mellitus Comorbidities at KHZ Musthafa Regional Hospital: from the provider’s perspective. Jurnal Ilmiah Farmako Bahari. 17, 2 (Jul. 2026), 195–203. DOI:https://doi.org/10.52434/jifb.v17i2.43785.